Australia markets closed

Landos Biopharma, Inc. (LABP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
22.47+0.12 (+0.54%)
At close: 04:00PM EDT
22.50 +0.03 (+0.13%)
After hours: 05:58PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.87-0.8-2.19-1.68
Low estimate-1.12-1.12-2.35-2.07
High estimate-0.63-0.48-2.03-1.3
Year ago EPS-0.63-0.94-3.5-2.19
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.1-0.88-0.91-1
Actual EPS-0.63-0.94-0.99-1.43
Difference0.47-0.06-0.08-0.43
Surprise %42.70%-6.80%-8.80%-43.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.87-0.8-2.19-1.68
7 days ago-0.87-0.8-2.19-1.68
30 days ago-0.87-0.8-2.19-1.68
60 days ago-0.91-0.94-2.5-1.13
90 days ago-0.91-0.94-2.5-1.13
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLABPIndustrySector(s)S&P 500
Current qtr.-38.10%N/AN/AN/A
Next qtr.14.90%N/AN/AN/A
Current year37.40%N/AN/AN/A
Next year23.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A